NCT01677286View on ClinicalTrials.gov

Safety and Effect of Doxycycline in Patients With Amyloidosis

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 22, 2015

Study Completion Date

December 15, 2015

Conditions
Amyloidosis
Interventions
DRUG

Doxycycline 100 mg po bid x 12 months

100mg by mouth twice daily for 1 year.

Trial Locations (1)

02118

Boston University, Boston

All Listed Sponsors
lead

Boston University

OTHER

NCT01677286 - Safety and Effect of Doxycycline in Patients With Amyloidosis | Biotech Hunter | Biotech Hunter